Skip to main content
. 2021 Jul 12;3(3):dlab087. doi: 10.1093/jacamr/dlab087

Table 4.

Overview of quality of prescription for antimicrobial drugs

Patients Anti-infective prescriptions Antibiotic prescriptions, n (%)
Antibiotic use guidelines available
Number Based on biomarkera
Reason in notes Stop/ review date Targeted treatmenta
CRP PCT WBC All
Hospital 1 (n = 318) 295 273 (92.5) 0 0 4 (2.5) 4 (2.5) 165 (60.4) 49 (17.9) 1 (0.4) none
Hospital 2 (n = 150) 154 140 (90.1) 0 0 24 (15.4) 24 (15.4) 47 (33.6) 79 (54.6) 0 none
Hospital 3 (n = 122) 148 137 (92.5) 0 0 0 0 82 (59.9) 103 (75.2) 0 none
Hospital 4 (n = 140) 193 161 (83.4) 0 0 13 (82.9) 13 (82.9) 108 (67.1) 113 (70.2) 3 (1.9) none
Hospital 5 (n = 629) 700 609 (87.0) 0 0 37 (23.7) 37 (23.7) 314 (51.6) 406 (66.7) 10 (1.6) none
Hospital 6 (n = 988) 967 890 (92.3) 7 (0.8) 6 (0.7) 34 (21.8) 46 (27.2) 388 (43.6) 201 (22.6) 31 (3.5) none
Hospital 7 (n = 550) 418 410 (98.1) 0 0 44 (28.2) 44 (26.0) 158 (38.5) 275 (67.1) 8 (2.0) none
Total (n = 2897) 2875 2620 (91.1) 7 (0.5) 6 (0.4) 156 (11.4) 169 (12.4) 1262 (48.2) 1226 (46.7) 53 (3.9)
a

Antibiotic prescriptions for systemic therapeutic use only (i.e., healthcare-associated or community-acquired infection, n = 1367); CRP, C-reactive protein; PCT, procalcitonin; WBC, white blood cells.